5150 CIBOMA/2004–01: a randomised phase III trial assessing adjuvant capecitabine (X) maintenance therapy after standard chemotherapy for triple-negative early breast cancer (EBC)
Lluch, A., Torrecillas, L., Barrios, C.H., Bines, J., Gómez, H., Getulio, J., Ruiz-Borrego, M., De la Haba, J., Torres, R., Ruiz, A.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71042-0
Date:
September, 2009
File:
PDF, 48 KB
english, 2009
File converter
More search results
More benefits 
